Press releases

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will host an Investor Day for institutional investors and financial analysts on...

Q4 revenue of $5.3 billion increased 5.4% as reported, 5.6% FXN Q4 GAAP and adjusted diluted EPS of $2.52 and $4.15, respectively FY26 revenue of $19.5 billion increased 4.9% as reported, 3.9% FXN...

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, has declared a quarterly dividend of $1.06 per common share, an increase of...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Bridget Bagnato has been appointed worldwide president of its Peripheral...

The launch of the Liverty™ TIPS Stent Graft gives physicians flexibility to tailor treatment for patients. FRANKLIN LAKES, N.J., Oct. 28, 2026 /PRNewswire/ -- BD (Becton, Dickinson and Company)...

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that BD management will host an audio webcast at 8 a.m. ET on Thursday, November 5,...

Physicians, policymakers, and global health experts urge broader access to monitoring technologies that can help identify life-threatening complications earlier, helping more mothers survive...

Data through 9 months of follow-up from this ongoing 36-month study demonstrate high vessel patency, low reintervention rates and meaningful improvements in mobility and symptoms, providing...

Generations of Connecticut employees have helped ensure the reliable supply of the BD® Syringe, an essential medical device clinicians rely on every day in patient care around the world CANAAN, Conn.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that Ferass Abuzaina has been named worldwide president of the Surgery business unit at...